The question "how long will I live?" has evolved from philosophical speculation to data-driven clinical science. Longevity medicine — a rapidly expanding subspecialty blending internal medicine, preventive cardiology, metabolic health, and geroscience — now offers a battery of measurable biomarkers that predict mortality risk with greater accuracy than chronological age alone. Studies consistently show that biological age, measured through several validated tools, can diverge from calendar age by 10–20 years in either direction.
Epigenetic Clocks: Reading the Methylation Code
DNA methylation clocks — computational models that analyze patterns of methyl groups attached to cytosine bases across thousands of genomic sites — have emerged as the most powerful predictors of biological aging available today. The Horvath Clock (2013), the PhenoAge clock, and the newer DunedinPACE (pace of aging) metric can predict all-cause mortality, cancer incidence, and cardiovascular events independently of traditional risk factors. Commercial tests including TruAge, Elysium Index, and Biological Age by Chronomics now make these metrics accessible to clinicians and consumers. A landmark 2024 study in Nature Aging found that DunedinPACE score predicted 5-year mortality with a C-statistic of 0.76 — comparable to established cardiovascular risk scores built on a dozen lab values.
VO2 Max: The Single Best Predictor of Longevity
Cardiorespiratory fitness, measured as VO2 max (maximal oxygen uptake in mL/kg/min), has emerged as what cardiologist Dr. Peter Attia calls "the most powerful marker we have" for predicting longevity. A 2018 JAMA Network Open analysis of 122,000 patients found that low cardiorespiratory fitness carried a mortality hazard ratio of 5.04 — exceeding smoking (2.53), diabetes (2.48), and hypertension (1.82). Every 1 MET increase in fitness (≈3.5 mL/kg/min VO2 max) reduces all-cause mortality by approximately 13%. Elite-level VO2 max in a 60-year-old is associated with all-cause mortality equivalent to an unfit 40-year-old.
Grip Strength, Gait Speed, and Muscle Mass
Three functional biomarkers require no lab draw and yet predict nursing home admission, disability, and mortality with remarkable precision. Grip strength below 26 kg (men) or 16 kg (women) — measured with a hand dynamometer — is a clinical criterion for sarcopenia and independently predicts 10-year mortality. Gait speed below 0.8 m/s in community-dwelling adults over 65 predicts falls, hospitalization, and death. Appendicular lean mass index below 7.0 (men) or 5.5 kg/m² (women) indicates sarcopenia requiring intervention. These can be assessed during a routine clinical encounter using equipment costing less than $200.
Metabolic Health Markers
Fasting insulin, HOMA-IR, triglyceride-to-HDL ratio, and continuous glucose monitoring (CGM) metrics including mean glucose, time-in-range, and glucose variability provide a far more granular picture of metabolic health than HbA1c alone. Studies show that up to 87% of American adults are metabolically unhealthy by at least one criterion even when not formally diabetic. Metabolic syndrome — defined by the presence of three or more of: elevated waist circumference, elevated triglycerides, low HDL, elevated blood pressure, and elevated fasting glucose — doubles cardiovascular mortality risk and is associated with a 5.4-year reduction in life expectancy.
Inflammation: hsCRP, IL-6, and Inflammaging
Chronic low-grade inflammation — termed "inflammaging" — is a hallmark of biological aging implicated in virtually all age-related diseases. High-sensitivity C-reactive protein (hsCRP) above 3.0 mg/L in the absence of acute illness predicts major adverse cardiovascular events (MACE) with a hazard ratio of 2.1. Interleukin-6 (IL-6), once primarily a research marker, is increasingly used in clinical longevity panels. The CANTOS trial proved that targeting IL-1β (upstream of IL-6) with canakinumab reduced non-fatal MI, stroke, and cardiovascular death by 15% — the first intervention to reduce MACE by anti-inflammatory mechanism alone, validating the inflammaging hypothesis.
Telomere Length
Telomere length — the protective caps on chromosome ends that shorten with each cell division — has long been studied as an aging biomarker. While predictive value at the individual level remains imperfect (high inter-assay variability), population-level associations are strong: lowest-quartile telomere length is associated with 1.5× greater mortality risk. Lifestyle factors with the strongest evidence for telomere preservation include: aerobic exercise (150+ min/week), Mediterranean diet, stress reduction, and sleep optimization (7–9 hours).
Actionable Longevity Protocols
The longevity medicine consensus — developed across institutions including the Buck Institute for Research on Aging, Karolinska Institute, and several academic longevity clinics — centers on four pillars: (1) exercise (strength + Zone 2 cardio), (2) metabolic optimization (diet quality, time-restricted eating, CGM-guided glucose control), (3) sleep quality (circadian alignment, sleep apnea screening and treatment), and (4) cognitive/emotional health. Healthcare facilities providing preventive care and longevity programs should stock diagnostic equipment for functional testing, including pulse oximeters, spirometers, and bioimpedance analyzers available in our catalog.
